BETHESDA, Md., Sept. 17 /PRNewswire/ -- United BioSource Corporation (UBC) today announced the acquisition of Caro Research, Inc., a leading provider of simulation technologies that help pharmaceutical and life science companies assess costs and benefits associated with health care. With extensive knowledge of cost data sources and population databases, Caro’s team has established methods of collecting, handling and analyzing cost and clinical data to support the development and commercialization of drugs, devices, diagnostics and procedures. The acquisition of Caro Research continues UBC’s commitment to invest in technology and scientific leadership to support its clients in meeting the increasing requirements for real-world evidence.
(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )
“Caro Research is the unquestioned leader in simulation modeling applied to the issues of value and safety of medical products,” said UBC’s CEO Ethan Leder. “These techniques, at the forefront of health care decision making, give innovative companies the ability to project how their product will perform in the real world from both an economic and clinical perspective.” Leder continued, “We are proud to have Dr. Caro and his team of distinguished scientists and technologists join our health care analytics team. In addition to leading-edge scientific capability, Caro Research expands our scientific presence in the European, Canadian and Latin American markets.”
“UBC is an ideal fit with the mission and capabilities of Caro Research,” said Jaime Caro, MD, founder and CEO of Caro Research. “Our organizations know and respect each other from working collaboratively on many projects. Together, we can capitalize on UBC’s reach, resources and scientific expertise to meet the exploding demand for our technology, analytical and data services.”
Dr. Caro will be responsible for the scientific and strategic direction of UBC’s health economics services. Together with Caro Research, UBC’s global health care analytics and data services will have a presence in the United States, Belgium, Canada, Colombia, Czech Republic, Germany, Hungary, Spain, Sweden and the United Kingdom.
Since 1993, Caro Research, Inc., headquartered in Concord, Massachusetts, has been the premier provider of complex modeling techniques, including discrete event simulation (DES). Its multi-national staff is comprised of investigators in medicine, epidemiology, economics, biostatistics, informatics and health care policy. For more information, visit http://www.caroresearch.com.
United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in new and innovative ways to study drugs and devices by offering expertise in science, strategy and execution.
UBC is headquartered in Bethesda, Maryland, with offices located in the United States, Canada, Europe, and South America. For more information, visit http://www.unitedbiosource.com or call 866-458-1096.
Tess Drahzal +1 (240) 644-0420; info@unitedbiosource.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comUnited BioSource Corporation
CONTACT: Tess Drahzal of United BioSource Corporation, +1-240-644-0420,info@unitedbiosource.com
